Oddo BHF - Indices PMI zone euro, PIB US, RÃ©union de la BCE

Report

Oddo BHF

Bruno Cavalier

Indices PMI zone euro, PIB US, RÃ©union de la BCE

...

23/07/2018 3 FR

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Bruno Cavalier

Other Reports from Oddo BHF

Markus Schmitt

Markus Schmitt

Stada Arzneimittel : We adopt a Buy recommendation on Stada’s new 2032 SS FRNs

In our credit research we said that we see an entry point for the new 2032 SS FRNs at a minimum yield of 5%. Stada priced the new instrument now at E+325bp. As such we adopt a Buy recommendation. Our Credit Opinion is Stable.

1m 1m 1 EN

Aurelien Sivignon

Aurelien Sivignon

Exail Technologies : ICG exit shaping up in the best possible way

7m 7m 1 EN

Markus Schmitt

Markus Schmitt

Stada Arzneimittel : We adopt a Buy recommendation on Stada’s new 2032 SS FRNs

13m 13m 1 FR

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Indices PMI zone euro, PIB US, RÃ©union de la BCE

Stada Arzneimittel : We adopt a Buy recommendation on Stada’s new 2032 SS FRNs

Exail Technologies : ICG exit shaping up in the best possible way

Stada Arzneimittel : We adopt a Buy recommendation on Stada’s new 2032 SS FRNs

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe